Registry for Adults With Plasma Cell Disorders (PCD's)

Part of paid clinical trials in Chapel Hill, North Carolina.

Sponsor
UNC Lineberger Comprehensive Cancer Center
Study ID
NCT03717844
Status
Recruiting
Apply to this trial

Conditions

  • Amyloidosis
  • Castleman's Disease
  • Cryoglobulinemia
  • Heavy Chain Deposition Disease
  • Light Chain Deposition Disease
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes
  • Smoldering Multiple Myeloma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The primary purpose of this protocol is to create a registry of patients with plasma cell disorders (PCDs), including for example the cancer multiple myeloma (MM), who complete the assessment, previously known as a "geriatric assessment," as is outlined in this protocol. Secondary objectives include measuring the response rate to participation of patients in this study, assessing patient satisfaction with the questionnaire, and gathering information that would lend support for future research into these types of assessments in patients with PCDs. Additionally the study offers an optional blood draw to look at a genetic marker of aging called p16INK4a (IRB 15-1899, IRB 15-0244).

Key Dates

Start date
Feb 9, 2018
Status verified
Nov 2025
Primary completion
Feb 29, 2028
Completion
Feb 28, 2029

Study Design

Enrollment
2,000 participants (estimated)

Primary Outcome Measure

Creation of a Registry of Plasma Cell Disorder (PCD) patients [ Time Frame: 10 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
North Carolina Cancer HospitalChapel HillNorth Carolina27599
Sascha Tuchman, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chapel Hill, NC

By condition
Multiple myeloma
By specialty
OncologyBlood cancer
By research site
North Carolina Cancer Hospital· Chapel Hill, NC

Related Studies